Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques
Abstract Antibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV) infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus components is less clear. Using a heterologous prime-boost strategy in rhesus macaques, we examine the effect of...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8ee938ae9d948e0b132ccac35634eaa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d8ee938ae9d948e0b132ccac35634eaa |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d8ee938ae9d948e0b132ccac35634eaa2021-12-02T15:45:20ZEnhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques10.1038/s41541-021-00339-y2059-0105https://doaj.org/article/d8ee938ae9d948e0b132ccac35634eaa2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00339-yhttps://doaj.org/toc/2059-0105Abstract Antibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV) infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus components is less clear. Using a heterologous prime-boost strategy in rhesus macaques, we examine the effect of priming with DENV purified inactivated vaccines (PIVs) on a tetravalent live attenuated vaccine (LAV). Sera exhibited low-level neutralizing antibodies (NAb) post PIV priming, yet moderate to high in vitro ADE activity. Following LAV administration, the PIV primed groups exhibited DENV-2 LAV peak viremias up to 1,176-fold higher than the mock primed group, and peak viremia correlated with in vitro ADE. Furthermore, PIV primed groups had more balanced and higher DENV-1–4 NAb seroconversion and titers than the mock primed group following LAV administration. These results have implications for the development of effective DENV vaccine prime-boost strategies and for our understanding of the role played by ADE in modulating DENV replication.Michael K. McCrackenCaitlin H. KuklisChandrika B. KannadkaDavid A. BarvirMark A. SanbornAdam T. WaickmanHayden C. SiegfriedKaitlin A. VictorKristin L. HatchRafael De La BarreraShannon D. WallsWiriya RutvisuttinuntJeffrey R. CurrierHeather FribergRichard G. JarmanGregory D. GromowskiNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Michael K. McCracken Caitlin H. Kuklis Chandrika B. Kannadka David A. Barvir Mark A. Sanborn Adam T. Waickman Hayden C. Siegfried Kaitlin A. Victor Kristin L. Hatch Rafael De La Barrera Shannon D. Walls Wiriya Rutvisuttinunt Jeffrey R. Currier Heather Friberg Richard G. Jarman Gregory D. Gromowski Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
description |
Abstract Antibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV) infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus components is less clear. Using a heterologous prime-boost strategy in rhesus macaques, we examine the effect of priming with DENV purified inactivated vaccines (PIVs) on a tetravalent live attenuated vaccine (LAV). Sera exhibited low-level neutralizing antibodies (NAb) post PIV priming, yet moderate to high in vitro ADE activity. Following LAV administration, the PIV primed groups exhibited DENV-2 LAV peak viremias up to 1,176-fold higher than the mock primed group, and peak viremia correlated with in vitro ADE. Furthermore, PIV primed groups had more balanced and higher DENV-1–4 NAb seroconversion and titers than the mock primed group following LAV administration. These results have implications for the development of effective DENV vaccine prime-boost strategies and for our understanding of the role played by ADE in modulating DENV replication. |
format |
article |
author |
Michael K. McCracken Caitlin H. Kuklis Chandrika B. Kannadka David A. Barvir Mark A. Sanborn Adam T. Waickman Hayden C. Siegfried Kaitlin A. Victor Kristin L. Hatch Rafael De La Barrera Shannon D. Walls Wiriya Rutvisuttinunt Jeffrey R. Currier Heather Friberg Richard G. Jarman Gregory D. Gromowski |
author_facet |
Michael K. McCracken Caitlin H. Kuklis Chandrika B. Kannadka David A. Barvir Mark A. Sanborn Adam T. Waickman Hayden C. Siegfried Kaitlin A. Victor Kristin L. Hatch Rafael De La Barrera Shannon D. Walls Wiriya Rutvisuttinunt Jeffrey R. Currier Heather Friberg Richard G. Jarman Gregory D. Gromowski |
author_sort |
Michael K. McCracken |
title |
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
title_short |
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
title_full |
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
title_fullStr |
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
title_full_unstemmed |
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
title_sort |
enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/d8ee938ae9d948e0b132ccac35634eaa |
work_keys_str_mv |
AT michaelkmccracken enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT caitlinhkuklis enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT chandrikabkannadka enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT davidabarvir enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT markasanborn enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT adamtwaickman enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT haydencsiegfried enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT kaitlinavictor enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT kristinlhatch enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT rafaeldelabarrera enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT shannondwalls enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT wiriyarutvisuttinunt enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT jeffreyrcurrier enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT heatherfriberg enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT richardgjarman enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques AT gregorydgromowski enhanceddenguevaccinevirusreplicationandneutralizingantibodyresponsesinimmuneprimedrhesusmacaques |
_version_ |
1718385779163529216 |